Literature DB >> 3940657

Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening.

J S Spratt, R A Greenberg, L S Heuser.   

Abstract

The purpose of this study is to report the time elapsing between the moment a breast cancer reaches threshold size that would permit detection and the size at actual detection defined as sojourn time (STt) using data from the Breast Cancer Detection and Demonstration Project (Louisville data and reported composite data from 27 centers) by dividing prevalence rates by incidence rates. The number of cellular generations (n) required to produce cancers of different volumes was calculated at threshold (nt), at detection (nd), and the difference between the two (nd - nt). By dividing the difference (nd - nt) into STt, the average actual or net tumor volume doubling time (DTact) in this interval have been estimated. The STt value for carcinoma in situ was 557 and for cancer it was 538. At ages 35-39, STt ranged from 365-456 days, by ages 70-74, 942-1383 days. The average DTact similarly varied with age, carcinoma in situ, cancer with negative axillary nodes, and cancer with positive axillary nodes over a range of 28-732 days (95% confidence). The estimated DTact in the predetectable period was manyfold less than the DTact measured for mammographically visible cancers, in keeping with the predictions of decelerating growth. Models of the cytokinetic and clinical behavior of breast cancer are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3940657

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.

Authors:  Dongfeng Wu; Gary L Rosner; Lyle Broemeling
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

2.  Timeliness of follow-up after abnormal screening mammography.

Authors:  K Kerlikowske
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.

Authors:  C T Brekelmans; P Westers; J A Faber; P H Peeters; H J Collette
Journal:  J Epidemiol Community Health       Date:  1996-02       Impact factor: 3.710

4.  Brachytherapy with Iodine-125 seeds strand for treatment of main portal vein tumor thrombi: an experimental study in a rabbit model.

Authors:  Wen Zhang; Jianjun Luo; Qingxin Liu; Jingqin Ma; Xudong Qu; Minjie Yang; Zhiping Yan; Jianhua Wang
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

5.  Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.

Authors:  Richard J Santen; Wei Yue; Daniel F Heitjan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-14       Impact factor: 4.254

6.  In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.

Authors:  Tae-Kyung Yoo; Jun Won Min; Min Kyoon Kim; Eunshin Lee; Jongjin Kim; Han-Byoel Lee; Young Joon Kang; Yun-Gyoung Kim; Hyeong-Gon Moon; Woo Kyung Moon; Nariya Cho; Dong-Young Noh; Wonshik Han
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.